SNNC (Sibannac) Current Deferred Revenue: $0.00 Mil (As of Feb. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Sibannac Current Deferred Revenue?

Sibannac SNNC -5.56% Current Deferred Revenue is $0.00 Mil as of Feb. 2017.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Sibannac's current deferred revenue for the quarter that ended in Feb. 2017 was $0.00 Mil.

Sibannac Current Deferred Revenue Related Terms

Sibannac Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Sibannac's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sibannac Current Deferred Revenue Chart

Sibannac Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sibannac Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a Current Deferred Revenue of $0.00 Mil mean?
Sibannac (SNNC) has a Current Deferred Revenue of $0.00 Mil as of Feb. 2017. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Sibannac and its competitors.
Is Sibannac's Current Deferred Revenue too high?
Sibannac's current Current Deferred Revenue is $0.00 Mil.
How does Sibannac's Current Deferred Revenue compare to LIVC and OTTV?
Sibannac's Current Deferred Revenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Sibannac and its competitors. Sibannac's current Current Deferred Revenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sibannac stock overvalued right now?
Sibannac (SNNC) has a current Current Deferred Revenue of $0.00 Mil. The current Current Deferred Revenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Sibannac (SNNC), the current Current Deferred Revenue is $0.00 Mil as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sibannac Business Description

Address 8657 N Caballo Circle, Paradise Valley, AZ, USA, 85253
Sibannac Inc is a cannabis research and development company with a portfolio of hemp beauty and body products, hemp animal care products, hemp clothing and accessories, and hemp paper and plastic products. Its products include oils, creams, lotions, treats, foods, shirts, pants, and dresses, and it also develops new hemp products. The group manufactures its products in Geneva, New York, and Charlotte, North Carolina. Its subsidiary business units include NOHO, Cherryology, and RaD8 Life, and associated brands include NOHO, Higher Times, Starwalker Cafe, The Meru Sky, consumer brands such as Converse, Titleist, FootJoy, Coca-Cola, Pepperidge Farm, and practitioner and nutraceutical brands including ChiroTouch, Emerson Ecologics, Reserveage, Gaia Herbs, Organic India, and NeoCell.